Study Stopped
Feasibility
Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer
A Study of the Feasibility and Acceptability of a Psycho-Educational Cognition Intervention in Adolescents and Young Adults (AYAs) With Cancer
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
This pilot trial studies how well a psycho-educational program called Emerging from the Haze works in helping patients with blood and lymph cancer. Sometimes, patients who have undergone treatment for cancer experience thinking or memory problems that make work, school, or everyday life activities, such as grocery shopping, difficult. The Emerging from the Haze program may provide resources to help deal with these types of challenges in patients with blood and lymph cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2019
CompletedFirst Posted
Study publicly available on registry
January 15, 2019
CompletedStudy Start
First participant enrolled
February 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2020
CompletedDecember 17, 2020
December 1, 2020
Same day
January 11, 2019
December 15, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Enrollment of eligible participants (accrual)
Feasibility will be assessed through enrollment of \>= 60% of eligible participants (accrual) and completion of at least 5 out of 6 sessions for \>= 80% of participants (adherence/engagement).
Up to 30 days post the end of the six-week program
Completion of sessions (adherence/engagement)
Feasibility will be assessed through enrollment of \>= 60% of eligible participants (accrual) and completion of at least 5 out of 6 sessions for \>= 80% of participants (adherence/engagement).
Up to 30 days post the end of the six-week program
Secondary Outcomes (5)
Change in Functional Assessment of Cancer Therapy-Cognition scores
Baseline up to 30 days post the end of the six-week program
Change in Patient Reported Outcomes Measurement Information System (PROMIS) scores
Baseline up to 30 days post the end of the six-week program
Change in Global Self-Report of Cognition scores
Baseline up to 30 days post the end of the six-week program
Change in PROMIS-29 items (29) scores
Baseline up to 30 days post the end of the six-week program
Satisfaction Survey scores
Up to 30 days post the end of the six-week program
Study Arms (1)
Supportive Care (psycho-educational sessions)
EXPERIMENTALPatients participate in a psycho-educational program weekly over 2 hours for 6 weeks.
Interventions
Attend Emerging from the Haze psychoeducational sessions
Ancillary studies
Eligibility Criteria
You may qualify if:
- A diagnosis of a hematological malignancy.
- Having received chemotherapy with or without radiation therapy.
- Physician approval.
- Functional Assessment of Cancer Therapy-Cognition (FACT-COG) score \< 59 on the perceived cognitive impairments (PCI) subscale.
- Eligible after 2 months (60 +/- 5 days) of completing all their active cancer treatment with the exception of patients that are post-transplant.
- Subjective complaint of cognitive concerns at time of enrollment.
- Must be able to understand and communicate proficiently in English.
- Ability to understand and the willingness to sign a written informed consent.
- Agree to complete study surveys.
You may not qualify if:
- Patients who have significant personality disorders or unstable psychiatric disorders as assessed by the interviewing clinician.
- Patients with known brain metastases, history of brain metastases or radiation to the brain.
- Patients with a history of stroke or other pre-existing neurological condition that may contribute to cognitive dysfunction.
- Non-English speaking patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- City of Hope Medical Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
City of Hope Medical Center
Duarte, California, 91010, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Natalie Kelly, PhD
City of Hope Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2019
First Posted
January 15, 2019
Study Start
February 10, 2020
Primary Completion
February 10, 2020
Study Completion
February 10, 2020
Last Updated
December 17, 2020
Record last verified: 2020-12